Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
The Procter & Gamble Company disclosed that its Board of Directors declared a quarterly dividend of $1.0568 per share on its Common Stock and on its Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after February 17, 2026 to Common Stock shareholders of record at the close of business on January 23, 2026, and to the ESOP preferred shareholders of record at the start of business on the same date. This filing simply reports the Board’s latest dividend decision under Regulation FD.
The Procter & Gamble Company disclosed that Jennifer Davis, currently Chief Executive Officer - Health Care, has notified the company of her intent to retire. The notice was given on December 9, 2025, and her retirement is expected to be effective June 30, 2026.
Davis is retiring after more than 33 years of service with Procter & Gamble, reflecting a long tenure in senior leadership. The filing does not provide additional details on succession or changes to the company’s broader strategy.
Procter & Gamble (PG) director Robert Portman reported a small equity compensation grant. On 12/09/2025, he acquired 54 shares of Procter & Gamble common stock through restricted stock units at a price of $0, reflecting a stock-based award rather than an open-market purchase.
The award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in the form of additional restricted stock units. Following this transaction, Portman beneficially owns 4,983.9036 shares of Procter & Gamble common stock in direct ownership.
Procter & Gamble director reports stock award under compensation plan. A company director received an award of 215 shares of Procter & Gamble common stock on 12/09/2025, recorded at a price of $0 per share. The award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Following this grant, the director directly beneficially owns 5,562.7456 shares of common stock. This total includes dividend equivalents that were granted in the form of restricted stock units, so it reflects both shares and related stock-based incentives.
Procter & Gamble reported an insider equity award for director Christine M. McCarthy on Form 4. On 12/09/2025, she received 269 shares of Procter & Gamble common stock in the form of Restricted Stock Units, shown at a price of $0 per unit because they are part of her compensation rather than an open-market purchase. These units were granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and her total beneficial ownership after this award is 16,808.9761 shares.
The total ownership figure also includes dividend equivalents that are credited as additional Restricted Stock Units, which means her position can gradually grow as dividends are paid. This filing reflects routine equity compensation for a board member, rather than a large discretionary buy or sale in the market.
Procter & Gamble (PG) reported an insider equity grant to one of its directors. On 12/09/2025, a director acquired 260 shares of common stock in the form of restricted stock units with a stated price of $0, reflecting an award rather than an open-market purchase. The award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and the director’s total beneficial ownership after this transaction is 10,978.2065 shares, including dividend equivalents granted as additional restricted stock units.
Procter & Gamble director Joseph Jimenez reported an equity award from the company. On 12/09/2025, he acquired 341 shares of common stock, shown at a price of $0, reflecting a grant of Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Following this award, he is shown as beneficially owning 36,083.677 shares of Procter & Gamble common stock in direct ownership. The total includes dividend equivalents granted in the form of additional Restricted Stock Units.
Procter & Gamble Co. reported an equity award to a director under its stock compensation plan. On 12/09/2025, a director of PROCTER & GAMBLE Co (PG) acquired 215 shares of common stock in the form of Restricted Stock Units at a price of $0, reflecting a non-cash grant under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
After this transaction, the director beneficially owned a total of 2,409.2016 shares, including dividend equivalents that were also granted as Restricted Stock Units. The filing is made as a Form 4 by one reporting person in the capacity of director, documenting routine equity-based compensation rather than an open-market purchase or sale.
Procter & Gamble Chairman, President and CEO Jon R. Moeller reported routine updates to his ownership of PG common stock. On 12/03/2025, several transactions occurred, including shares withheld to cover taxes related to previous restricted stock unit (RSU) grants, as noted in the explanations. These withholding transactions reduced his directly held common stock but reflect tax obligations rather than open‑market sales.
The report also shows ongoing activity in RSUs linked to dividend equivalents and the company’s retirement program. Certain RSUs represent a contingent right to receive Procter & Gamble common stock, generally delivering shares upon retirement unless delivery is deferred or contributed to a deferred compensation account. Moeller also reports indirect ownership through retirement plan trustees and holdings attributed to his spouse.
Procter & Gamble’s Chief Legal Officer and Secretary, Susan Street Whaley, reported routine equity compensation activity involving company stock. On 12/03/2025, she acquired 54.39 shares of common stock through the exercise of equity awards and had the same 54.39 shares withheld to cover taxes on a previous restricted stock unit grant, leaving her with 31,902.2845 directly held shares and 6,531.6011 shares held indirectly by a retirement plan trustee.
The filing also shows activity in restricted stock units (RSUs). On 11/17/2025, she received 12.8844 RSUs as dividend equivalents under a retirement program, and certain RSUs will convert into Procter & Gamble common stock upon retirement or may be deferred or settled in cash under the plan’s terms.
FAQ
What is the current stock price of Procter & Gamble (PG)?
What is the market cap of Procter & Gamble (PG)?
